Report Detail
Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Insights, Forecast to 2025
- RnM2953508 |
- 16 February, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In the last several years, the development of Liposomes Drug Delivery market is fast with an average growth rate of 13.52%. In 2017, the global revenue of Liposomes Drug Delivery market is nearly 2.30 billion USD.
North America dominated the market with market share of 42.44% due to the high medical level. Following North America, Europe is the second largest market with market share of 32.33%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 23.81%.
The global Liposome Drug Delivery (Liposomes Drug Delivery) market is valued at 2600 million US$ in 2018 and will reach 6040 million US$ by the end of 2025, growing at a CAGR of 12.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Liposome Drug Delivery (Liposomes Drug Delivery) market based on company, product type, end user and key regions.
This report studies the global market size of Liposome Drug Delivery (Liposomes Drug Delivery) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Liposome Drug Delivery (Liposomes Drug Delivery) in these regions.
This research report categorizes the global Liposome Drug Delivery (Liposomes Drug Delivery) market by top players/brands, region, type and end user. This report also studies the global Liposome Drug Delivery (Liposomes Drug Delivery) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau Group
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Market size by Product
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Market size by End User
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Liposome Drug Delivery (Liposomes Drug Delivery) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Liposome Drug Delivery (Liposomes Drug Delivery) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Liposome Drug Delivery (Liposomes Drug Delivery) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Liposome Drug Delivery (Liposomes Drug Delivery) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Liposome Drug Delivery (Liposomes Drug Delivery) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Vial). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Liposome Drug Delivery (Liposomes Drug Delivery) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Liposome Drug Delivery (Liposomes Drug Delivery) Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Size Growth Rate by Product
- 1.4.2 Liposomal Doxorubicin
- 1.4.3 Liposomal Amphoteracin B
- 1.4.4 Liposomal Paclitaxel
- 1.4.5 Others
- 1.5 Market by End User
- 1.5.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Size Growth Rate by End User
- 1.5.2 Fungal Infection Therapy
- 1.5.3 Cancer & Tumor Therapy
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Size
- 2.1.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue 2014-2025
- 2.1.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales 2014-2025
- 2.2 Liposome Drug Delivery (Liposomes Drug Delivery) Growth Rate by Regions
- 2.2.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales by Regions
- 2.2.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Liposome Drug Delivery (Liposomes Drug Delivery) Sales by Manufacturers
- 3.1.1 Liposome Drug Delivery (Liposomes Drug Delivery) Sales by Manufacturers
- 3.1.2 Liposome Drug Delivery (Liposomes Drug Delivery) Sales Market Share by Manufacturers
- 3.1.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Concentration Ratio (CR5 and HHI)
- 3.2 Liposome Drug Delivery (Liposomes Drug Delivery) Revenue by Manufacturers
- 3.2.1 Liposome Drug Delivery (Liposomes Drug Delivery) Revenue by Manufacturers (2014-2019)
- 3.2.2 Liposome Drug Delivery (Liposomes Drug Delivery) Revenue Share by Manufacturers (2014-2019)
- 3.3 Liposome Drug Delivery (Liposomes Drug Delivery) Price by Manufacturers
- 3.4 Liposome Drug Delivery (Liposomes Drug Delivery) Manufacturing Base Distribution, Product Types
- 3.4.1 Liposome Drug Delivery (Liposomes Drug Delivery) Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Liposome Drug Delivery (Liposomes Drug Delivery) Product Type
- 3.4.3 Date of International Manufacturers Enter into Liposome Drug Delivery (Liposomes Drug Delivery) Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales by Product
- 4.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue by Product
- 4.3 Liposome Drug Delivery (Liposomes Drug Delivery) Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Breakdown Data by End User
6 North America
- 6.1 North America Liposome Drug Delivery (Liposomes Drug Delivery) by Countries
- 6.1.1 North America Liposome Drug Delivery (Liposomes Drug Delivery) Sales by Countries
- 6.1.2 North America Liposome Drug Delivery (Liposomes Drug Delivery) Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Liposome Drug Delivery (Liposomes Drug Delivery) by Product
- 6.3 North America Liposome Drug Delivery (Liposomes Drug Delivery) by End User
7 Europe
- 7.1 Europe Liposome Drug Delivery (Liposomes Drug Delivery) by Countries
- 7.1.1 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Sales by Countries
- 7.1.2 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Liposome Drug Delivery (Liposomes Drug Delivery) by Product
- 7.3 Europe Liposome Drug Delivery (Liposomes Drug Delivery) by End User
8 Asia Pacific
- 8.1 Asia Pacific Liposome Drug Delivery (Liposomes Drug Delivery) by Countries
- 8.1.1 Asia Pacific Liposome Drug Delivery (Liposomes Drug Delivery) Sales by Countries
- 8.1.2 Asia Pacific Liposome Drug Delivery (Liposomes Drug Delivery) Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Liposome Drug Delivery (Liposomes Drug Delivery) by Product
- 8.3 Asia Pacific Liposome Drug Delivery (Liposomes Drug Delivery) by End User
9 Central & South America
- 9.1 Central & South America Liposome Drug Delivery (Liposomes Drug Delivery) by Countries
- 9.1.1 Central & South America Liposome Drug Delivery (Liposomes Drug Delivery) Sales by Countries
- 9.1.2 Central & South America Liposome Drug Delivery (Liposomes Drug Delivery) Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Liposome Drug Delivery (Liposomes Drug Delivery) by Product
- 9.3 Central & South America Liposome Drug Delivery (Liposomes Drug Delivery) by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Liposome Drug Delivery (Liposomes Drug Delivery) by Countries
- 10.1.1 Middle East and Africa Liposome Drug Delivery (Liposomes Drug Delivery) Sales by Countries
- 10.1.2 Middle East and Africa Liposome Drug Delivery (Liposomes Drug Delivery) Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Liposome Drug Delivery (Liposomes Drug Delivery) by Product
- 10.3 Middle East and Africa Liposome Drug Delivery (Liposomes Drug Delivery) by End User
11 Company Profiles
- 11.1 Gilead Sciences
- 11.1.1 Gilead Sciences Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Gilead Sciences Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Gilead Sciences Liposome Drug Delivery (Liposomes Drug Delivery) Products Offered
- 11.1.5 Gilead Sciences Recent Development
- 11.2 Pacira
- 11.2.1 Pacira Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Pacira Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Pacira Liposome Drug Delivery (Liposomes Drug Delivery) Products Offered
- 11.2.5 Pacira Recent Development
- 11.3 Sun Pharmaceutical
- 11.3.1 Sun Pharmaceutical Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Sun Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Sun Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Products Offered
- 11.3.5 Sun Pharmaceutical Recent Development
- 11.4 Johnson & Johnson
- 11.4.1 Johnson & Johnson Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Johnson & Johnson Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Johnson & Johnson Liposome Drug Delivery (Liposomes Drug Delivery) Products Offered
- 11.4.5 Johnson & Johnson Recent Development
- 11.5 Luye Pharma
- 11.5.1 Luye Pharma Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Luye Pharma Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Luye Pharma Liposome Drug Delivery (Liposomes Drug Delivery) Products Offered
- 11.5.5 Luye Pharma Recent Development
- 11.6 Sigma-Tau Group
- 11.6.1 Sigma-Tau Group Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Sigma-Tau Group Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Sigma-Tau Group Liposome Drug Delivery (Liposomes Drug Delivery) Products Offered
- 11.6.5 Sigma-Tau Group Recent Development
- 11.7 Ipsen (Onivyde)
- 11.7.1 Ipsen (Onivyde) Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Ipsen (Onivyde) Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Ipsen (Onivyde) Liposome Drug Delivery (Liposomes Drug Delivery) Products Offered
- 11.7.5 Ipsen (Onivyde) Recent Development
- 11.8 CSPC
- 11.8.1 CSPC Company Details
- 11.8.2 Company Business Overview
- 11.8.3 CSPC Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 CSPC Liposome Drug Delivery (Liposomes Drug Delivery) Products Offered
- 11.8.5 CSPC Recent Development
- 11.9 Teva Pharmaceutical
- 11.9.1 Teva Pharmaceutical Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Teva Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Teva Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Products Offered
- 11.9.5 Teva Pharmaceutical Recent Development
- 11.10 Novartis
- 11.10.1 Novartis Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Novartis Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Novartis Liposome Drug Delivery (Liposomes Drug Delivery) Products Offered
- 11.10.5 Novartis Recent Development
- 11.11 Fudan-Zhangjiang
12 Future Forecast
- 12.1 Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast by Regions
- 12.1.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales Forecast by Regions 2019-2025
- 12.1.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue Forecast by Regions 2019-2025
- 12.2 Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast by Product
- 12.2.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Sales Forecast by Product 2019-2025
- 12.2.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue Forecast by Product 2019-2025
- 12.3 Liposome Drug Delivery (Liposomes Drug Delivery) Market Forecast by End User
- 12.4 North America Liposome Drug Delivery (Liposomes Drug Delivery) Forecast
- 12.5 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Forecast
- 12.6 Asia Pacific Liposome Drug Delivery (Liposomes Drug Delivery) Forecast
- 12.7 Central & South America Liposome Drug Delivery (Liposomes Drug Delivery) Forecast
- 12.8 Middle East and Africa Liposome Drug Delivery (Liposomes Drug Delivery) Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Liposome Drug Delivery (Liposomes Drug Delivery) Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Liposome Drug Delivery (Liposomes Drug Delivery) . Industry analysis & Market Report on Liposome Drug Delivery (Liposomes Drug Delivery) is a syndicated market report, published as Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Liposome Drug Delivery (Liposomes Drug Delivery) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
